Other
Share Repurchase Program, Remaining Authorized, Amount
AbbVie Share Repurchase Program, Remaining Authorized, Amount decreased by 37.9% to $1.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.9%, from $2.90B to $1.80B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2016
Last reportedQ1 2026May 8, 2026
How to read this metric
A high remaining balance indicates potential future support for the stock price through buybacks.
Detailed definition
This is the portion of the board-authorized share repurchase program that has not yet been executed. It indicates the re...
Peer comparison
Used by investors to gauge the near-term potential for share count reduction and capital return.
Metric ID:
other_stock_repurchase_program_remaining_authorized_repu_889179Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60B | $2.60B | $1.40B | $1.40B | $1.40B | $4.80B | $4.80B | $4.80B | $3.90B | $3.90B | $3.90B | $2.90B | $2.90B | $2.90B | $1.80B |
| QoQ Change | — | +0.0% | -46.2% | +0.0% | +0.0% | +242.9% | +0.0% | +0.0% | -18.8% | +0.0% | +0.0% | -25.6% | +0.0% | +0.0% | -37.9% |
| YoY Change | — | — | — | -46.2% | -46.2% | +242.9% | +242.9% | +242.9% | -18.8% | -18.8% | -18.8% | -25.6% | -25.6% | -25.6% | -37.9% |
Range$1.40B – $4.80B
CAGR-10.0%
Avg YoY Growth+38.8%
Median YoY Growth-22.2%
Share Repurchase Program, Remaining Authorized, Amount at Other Companies
Frequently Asked Questions
- What is AbbVie's share repurchase program, remaining authorized, amount?
- AbbVie (ABBV) reported share repurchase program, remaining authorized, amount of $1.80B in Q1 2026.
- How has AbbVie's share repurchase program, remaining authorized, amount changed year-over-year?
- AbbVie's share repurchase program, remaining authorized, amount decreased by 37.9% year-over-year, from $2.90B to $1.80B.
- What does share repurchase program, remaining authorized, amount mean?
- The dollar amount of the share repurchase program that is still available to be used.